Boothbay Fund Management’s Guardant Health GH Stock Holding History

Boothbay Fund Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-50,000	Closed	-$1.15M	–	1653
2024 Q3	$1.15M	Buy	+50,000	New	+$1.42M	0.03%	710

Other funds holding GH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boothbay Fund Management's GH Position: Q1 2026 in Review

Boothbay Fund Management sold out of Guardant Health (GH) in Q1 2026, closing a stake of 7,737 shares — an estimated $790K sold.

Boothbay Fund Management first reported a position in GH in Q2 2023 and held it in 4 quarters. The position peaked at $2.06M in Q1 2024. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

Boothbay Fund Management reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
Boothbay Fund Management sold 7,737 Guardant Health shares in Q1 2026, an estimated $790K.
Boothbay Fund Management first reported a position in Guardant Health in Q2 2023 and held it in 4 quarters.
Boothbay Fund Management's Guardant Health position peaked at $2.06M in Q1 2024.
481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.